get started today

  • This field is for validation purposes and should be left unchanged.
  • This field is for validation purposes and should be left unchanged.

To protect you from COVID-19, we are offering a quick & easy remote intake process. Click here to learn more.

BACK

Email

MENU

call for a free consultation

Nationwide Recall of Zantec

Posted in Dangerous Drugs,Uncategorized,Zantec on June 30, 2020

Recently, the FDA directed that all ranitidine (Zantac) products be pulled from the market immediately. The recall includes all prescription and over-the-counter ranitidine drugs as ongoing investigations uncovered levels of N-Nitrosodimethylamine (NDMA), a probable human carcinogen, increase over time.

What is Ranitidin (Zantac)?

Ranitidine (also known by its brand name, Zantac, which is sold by the drug company Sanofi) is available over the counter (OTC) and by prescription. It belongs to the class of drugs known as H2 (or histamine-2) blockers. People use OTC ranitidine to relieve and prevent heartburn. Prescription strengths can treat and prevent more severe ulcers in the stomach and intestines. Multiple companies sell generic versions of both the OTC and prescription products.

 What is NDMA?

NDMA is classified as a probable human carcinogen that can form as a byproduct of industrial processes. This environmental contaminant is also found in water and foods, including dairy products, vegetables, and grilled meats, but in levels that are considered generally harmless. The NDMA found in the recalled Zantac and ranitidine products is above levels deemed safe by the FDA. 

On April 1, 2020, The FDA recommended the universal recall of all Zantac and ranitidine products from the U.S. market. The Zantac recall comes after various third-party tests have found that unsafe levels of the probable human carcinogen NDMA can be produced in Zantac and ranitidine products as they are stored over time or when exposed to high temperatures. The FDA Zantac recall includes both prescription and over-the-counter Zantac and ranitidine products.

NDMA exposure in Zantac and ranitidine has been linked to digestive system cancers such as:

  • Stomach cancer
  • Intestinal cancer (both of the small and large intestines)
  • Esophageal cancer
  • Prostate cancer
  • Pancreatic cancer
  • Leukemia
  • Non-Hodgkin’s Lymphoma
  • Multiple Myeloma
  • Bladder cancer
  • Stomach cancer
  • Colorectal Cancer
  • Liver Cancer
  • Kidney Cancer

Additionally, in babies born to mothers who took Zantac consistently throughout their pregnancies, NDMA has been linked to cancers, including brain cancers, in young children.

Do I Have a Case?

The Manchin Injury Law Group is currently investigating claims on behalf of Zantac users who developed cancer anytime after using Zantac. If you or a loved one used ranitidine (Zantac) and developed cancer, you may be eligible for an Injury Compensation Claim. Contact us today for a free legal consultation with one of our lawyers to discuss potentially filing a claim. Call us today! 800-557-4LAW